# Comparison of the Clinical Response of Total Neoadjuvant Treatment of Two Methods of Long-term or Short-term Chemoradiotherapy in Rectal Cancer

> **NCT05920928** · NA · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 114 (estimated)

## Conditions studied

- Locally Advanced Rectal Carcinoma

## Interventions

- **RADIATION:** Short course radiotherapy with concurrent capecitabine(825mg/m2)
- **RADIATION:** Long course radiotherapy with concurrent capecitabine(825mg/m2)

## Key facts

- **NCT ID:** NCT05920928
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-23
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-04-01
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05920928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05920928, "Comparison of the Clinical Response of Total Neoadjuvant Treatment of Two Methods of Long-term or Short-term Chemoradiotherapy in Rectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05920928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*